Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

被引:0
作者
Harvesh Kumar Rana
Amit Kumar Singh
Ramesh Kumar
Abhay K. Pandey
机构
[1] University of Allahabad,Department of Biochemistry
[2] Feroze Gandhi College,Department of Zoology
[3] BMK Government. Girls College,Department of Botany
[4] Central University of Punjab,Department of Biochemistry
关键词
Tuberculosis; Drug-resistance; Hepatoprotective; Natural products; Liver injury;
D O I
暂无
中图分类号
学科分类号
摘要
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis (TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb strains need longer and more expensive treatment with many medications resulting in more adverse effects and decreased chances of treatment outcomes. The World Health Organization (WHO) has emphasised the development of not just new individual anti-TB drugs, but also novel medication regimens as an alternative treatment option for the drug-resistant Mtb strains. Many plants, as well as marine creatures (sponge; Haliclona sp.) and fungi, have been continuously used to treat TB in various traditional treatment systems around the world, providing an almost limitless supply of active components. Natural products, in addition to their anti-mycobacterial action, can be used as adjuvant therapy to increase the efficacy of conventional anti-mycobacterial medications, reduce their side effects, and reverse MDR Mtb strain due to Mycobacterium’s genetic flexibility and environmental adaptation. Several natural compounds such as quercetin, ursolic acid, berberine, thymoquinone, curcumin, phloretin, and propolis have shown potential anti-mycobacterial efficacy and are still being explored in preclinical and clinical investigations for confirmation of their efficacy and safety as anti-TB medication. However, more high-level randomized clinical trials are desperately required. The current review provides an overview of drug-resistant TB along with the latest anti-TB medications, drug-induced hepatotoxicity and oxidative stress. Further, the role and mechanisms of action of first and second-line anti-TB drugs and new drugs have been highlighted. Finally, the role of natural compounds as anti-TB medication and hepatoprotectants have been described and their mechanisms discussed.
引用
收藏
页码:1251 / 1273
页数:22
相关论文
共 1065 条
  • [1] AbouZid SF(2016)Silymarin content in Industrial Crops and Products 2016 83 729-737
  • [2] Chen S-N(2016) populations growing in Egypt Drug Chem Toxicol 39 224-232
  • [3] Pauli GF(2009)Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria Respiratory Medicine 103 1777-1790
  • [4] Ahadpour M(2021)Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis Environ Sci Pollut Res 28 6195-6206
  • [5] Eskandari MR(2018)Protective efficacy of thymoquinone or ebselen separately against arsenic-induced hepatotoxicity in rat Sci Rep 8 12238-305
  • [6] Mashayekhi V(2014)Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach BMC Complement Altern Med 14 282-9
  • [7] Tehrani KHME(2018)Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa- β Pharmacological Research 128 288-9
  • [8] Jafarian I(2014)Antimicrobial peptides as an alternative to anti-tuberculosis drugs BioMed Res Int 2014 1-375
  • [9] Naserzadeh P(2012)The Structural Modeling of the Interaction between Levofloxacin and the J Hepatol 2012 1-1459
  • [10] Hosseini M-J(2005) Gyrase Catalytic Site Sheds Light on the Mechanisms of Fluoroquinolones Resistant Tuberculosis in Colombian Clinical Isolates Toxicol 208 367-8